Close Menu

IQvia

NEW YORK (GenomeWeb) – Global Genomics Group this week said it has finished enrolling a 7,500-patient cohort on which the company will collect and analyze 22 trillion data points, including omics data, and build a detailed network map of atherosclerotic cardiovascular disease (CVD).

NEW YORK (GenomeWeb News) – Global Genomics Group and Quintiles announced today a collaboration aimed at developing new diagnostic tools and treatments for cardiovascular diseases as part of the Genetic Loci and Burden of Atherosclerotic Lesions (GLOBAL) clinical study.

Early-access customers of a new sample loading device that Pacific Biosciences launched last week say that the upgrade improves results for certain samples, reduces contamination, and cuts down the amount of library material required per run.

NeoGenomics Launches Test to Gauge SF3B1 Mutations, Track Chronic Lymphocytic Leukemia Progression

Genomics services provider Expression Analysis will gain access to "unsurpassed global resources" and will be able to "close strategic relationships" with leading biopharmaceutical companies by becoming part of Quintiles, EA CEO Steve McPhail said this week.

NEW YORK (GenomeWeb News) – Biopharmaceutical services and clinical research organization Quintiles today said that it has acquired genomic services provider Expression Analysis.

NEW YORK (GenomeWeb News) – Expression Analysis has netted a $27 million contract from the Environmental Protection Agency to investigate toxicology-related RNA biomarkers for a set of up to 12,100 compounds in 121,100 biological samples being reviewed under EPA's ToxCast program, EA said today.

Expression Analysis is partnering with biotechnology firm HemoShear to generate and analyze RNA information from several thousand human samples that will populate a drug database that HemoShear is developing.

NEW YORK (GenomeWeb News) – HemoShear today announced a partnership with Expression Analysis to develop a database for evaluating the vascular pharmacology of new drug compounds.

Vermillion has nominated Paul Sohmer to stand for election to its board of directors at the company's upcoming board meeting.

Pages

The Washington Post reports on researchers' efforts to determine the effect of an increasingly common SARS-CoV-2 mutation.

Florida Politics reports Florida's law barring life, long-term care, and disability insurers from using genetic information in coverage decisions went into effect at the beginning of July.

A new analysis finds a link between popular media coverage of a scientific study and how often that paper is cited.

In Nature this week: CRISPR approaches to editing plant genomes, way to speed up DNA-PAINT, and more.